Viable Circulating Tumor Cells from Patient Blood: A Chip-Free Approach for Clinical Labs - CD

Viable Circulating Tumor Cells from Patient Blood
  • Copyright: 2013
  • Speaker: Michael King

Price: $119.00

Member Price: $99.00

Rating: Member Average

This webcast originally aired as a live webinar on January 8, 2013. Dr. Michael King describes approaches currently being used to isolate circulating tumor cells (CTCs), which are shed into the bloodstream from primary and metastatic cancers. King describes the limitations of existing CTC detection technologies, and current strategies being used to overcome them. You will also hear what isolation of these cells could mean for clinical research and the future of cancer therapy, as well as a technique for isolation of these cells developed by Cornell researchers that you can use in your lab.